Discover our analyses
This page lets you dive into all the analyses BII has carried out or commissioned. These analyses cover important topics, such as innovation potential and translational efficiency at the Danish universities, that shape the innovation landscape in which BioInnovation Institute operates. At BII, we believe that a thorough understanding of the ecosystem we are part of and the conditions affecting it are foundational for our work to support world-class life science innovation that drives development of new solutions by early life science start-ups for the benefit of people and society.
White paper: University Innovation
As significant public funds are currently allocated to research and universities worldwide, there is increasing pressure to demonstrate that research does not only end up in academic publications but leads to new inventions and innovations for the benefit of people and society.
So, how do we ensure the best framework for universities and researchers to convert research into innovation?
Read our full White Paper about the Danish universities’ large untapped biotech innovation potential and what can be done to realize it.
Analyses: Untap the Startup Potential
Over the last decade, the Danish life science industry has developed rapidly in terms of export and growth to become one of the biggest strongholds for Denmark. Research shows the importance of fostering a strong Danish ecosystem for research, development, and commercialization of new viable life science companies. The private Danish and international investments in R&D in Danish life science are continuously growing, and the number of life science startups that are seeking patents is proportionally high. Denmark, however, competes with a number of other strong, established, and leading life science hot spots that, too, perform very well in terms of commercialization of innovative ideas. As a result, it is essential to continuously strengthen the Danish life science startup ecosystem to continue attracting investments and developing new startups.
This study examines the state of the Danish life science startup ecosystem, its results and role, and the potential for future development.
The study is commissioned by BioInnovation Institute and the Novo Nordisk Foundation